Nemaura Medical (NMRD) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Nemaura Medical Short Interest DataNemaura Medical (NMRD) has a short interest of 400 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 8,159 shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.04Short Interest Ratio0.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares40,352,000 sharesShort Percent of Float0.00%Today's Trading Volume0 sharesAverage Trading Volume8,159 sharesToday's Volume Vs. Average0% Short Selling Nemaura Medical? Sign up to receive the latest short interest report for Nemaura Medical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNMRD Short Interest Over TimeNMRD Days to Cover Over TimeNMRD Percentage of Float Shorted Over Time Nemaura Medical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025400 shares $0.04 No Change0.0%0 $0.00 7/15/2025400 shares $0.04 No ChangeN/A0.5 $0.00 6/30/2025400 shares $0.04 No Change0.0%0.6 $0.00 6/15/2025400 shares $0.00 No Change0.0%0.2 $0.00 5/31/2025400 shares $0.00 No Change0.0%0.3 $0.00 5/15/2025400 shares $0.04 No ChangeN/A0.8 $0.00 4/30/2025400 shares $0.04 No ChangeN/A0.1 $0.00 4/15/2025400 shares $0.08 No ChangeN/A0.2 $0.00 3/14/2025400 shares $0.08 -33.3%N/A0.1 $0.00 2/14/2025600 shares $0.00 No ChangeN/A0.4 $0.00 Get the Latest News and Ratings for NMRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025600 shares $0.06 No ChangeN/A0 $0.00 1/15/2025600 shares $0.00 No ChangeN/A0.1 $0.00 12/31/202351,100 shares $11.19 thousand -2.9%0.3%0.3 $0.22 12/15/202352,600 shares $8.94 thousand -75.3%0.4%0.4 $0.17 11/30/2023212,700 shares $48.28 thousand +10.7%1.4%1.3 $0.23 11/15/2023192,200 shares $48.32 thousand +3.3%1.3%0.9 $0.25 10/31/2023186,100 shares $48.57 thousand +19.7%1.2%0.8 $0.26 10/15/2023155,500 shares $42.64 thousand -51.4%1.0%0.7 $0.27 9/30/2023319,700 shares $100.71 thousand -19.4%2.1%1.5 $0.32 9/15/2023396,800 shares $164.67 thousand +45.2%2.7%1.8 $0.42 8/31/2023273,300 shares $125.94 thousand +557.0%1.8%1.8 $0.46 8/15/202341,600 shares $34.11 thousand -2.4%0.3%0.5 $0.82 7/31/202342,600 shares $38.56 thousand +31.5%0.3%0.7 $0.91 7/15/202332,400 shares $30.78 thousand -53.8%0.2%0.6 $0.95 6/30/202370,100 shares $64.85 thousand -5.5%0.5%1.4 $0.93 6/15/202374,200 shares $48.64 thousand +28.8%0.5%1.9 $0.66 5/31/202357,600 shares $28.74 thousand +7.3%0.4%1.9 $0.50 5/15/202353,700 shares $35.44 thousand +68.9%0.4%1.7 $0.66 4/30/202331,800 shares $23.53 thousand -6.5%0.2%0.8 $0.74 4/15/202334,000 shares $28.90 thousand -38.3%0.2%0.2 $0.85 3/31/202355,100 shares $49.31 thousand +36.4%0.4%0.3 $0.90 3/15/202340,400 shares $31.11 thousand +7.2%0.3%0.3 $0.77 2/28/202337,700 shares $37.17 thousand -71.7%0.3%0.2 $0.99 2/15/2023133,300 shares $157.29 thousand -19.1%1.1%0.9 $1.18 1/31/2023164,700 shares $219.05 thousand +189.0%1.4%1.2 $1.33 1/15/202357,000 shares $96.33 thousand -9.7%0.6%2.8 $1.69 12/30/202263,100 shares $108.35 thousand -20.4%0.6%7.6 $1.72 12/15/202279,300 shares $164.13 thousand +3.0%0.8%8 $2.07 11/30/202277,000 shares $167.86 thousand -2.8%0.8%7.8 $2.18 11/15/202279,200 shares $166.32 thousand -2.5%0.8%7.9 $2.10BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.Claim your free copy of “How to Survive the Next Financial Crisis” today 10/31/202281,200 shares $196.50 thousand -4.4%0.8%7.7 $2.42 10/15/202284,900 shares $196.54 thousand +9.7%0.9%8 $2.32 9/30/202277,400 shares $160.99 thousand -8.0%0.8%7.1 $2.08 9/15/202284,100 shares $163.15 thousand -3.2%0.9%9.6 $1.94 8/31/202286,900 shares $165.11 thousand -8.7%0.9%10.3 $1.90 8/15/202295,200 shares $209.44 thousand -5.7%1.0%10.9 $2.20 7/31/2022100,900 shares $192.72 thousand -0.9%1.0%10.8 $1.91 7/15/2022101,800 shares $181.20 thousand -15.8%1.0%11.1 $1.78 6/30/2022120,900 shares $310.71 thousand -1.2%1.2%15.5 $2.57 6/15/2022122,400 shares $321.91 thousand -1.5%1.2%17.2 $2.63 5/31/2022124,200 shares $344.03 thousand -12.0%1.3%15.1 $2.77 5/15/2022141,200 shares $382.65 thousand +0.9%1.4%15.3 $2.71 4/30/2022140,000 shares $506.80 thousand -7.8%1.4%9.1 $3.62 4/15/2022151,800 shares $604.16 thousand -8.4%1.5%9.2 $3.98 3/31/2022165,700 shares $724.11 thousand +2.9%1.7%9.2 $4.37 3/15/2022161,100 shares $653.65 thousand -11.8%1.6%7.4 $4.06 2/28/2022182,700 shares $690.61 thousand -12.3%1.9%5.9 $3.78 2/15/2022208,200 shares $878.60 thousand +2.5%2.2%6.4 $4.22 1/31/2022203,100 shares $817.03 thousand -5.9%2.2%5.8 $4.02 1/15/2022215,800 shares $988.36 thousand +0.7%2.4%6.8 $4.58 12/31/2021214,300 shares $977.21 thousand +1.1%2.3%6.9 $4.56 12/15/2021211,900 shares $951.43 thousand +8.8%2.3%6.6 $4.49 11/30/2021194,700 shares $944.30 thousand -14.7%2.1%5.9 $4.85 11/15/2021228,300 shares $1.30 million -11.9%2.5%6.4 $5.71 10/29/2021259,000 shares $1.64 million -21.8%2.8%6.8 $6.35 10/15/2021331,100 shares $1.93 million -13.5%3.6%8.2 $5.83 9/30/2021382,900 shares $2.30 million -18.3%4.2%7.6 $6.01 9/15/2021468,600 shares $2.99 million -5.7%5.1%5.2 $6.39 8/31/2021496,900 shares $3.47 million +8.6%5.4%3.7 $6.99 8/13/2021457,700 shares $3.22 million -4.7%5.0%2.1 $7.03 7/30/2021480,300 shares $3.64 million -21.7%5.4%1.2 $7.58 7/15/2021613,600 shares $5.04 million -13.3%6.9%0.3 $8.21 6/30/2021707,300 shares $7.32 million -21.4%7.9%0.4 $10.35 6/15/2021900,100 shares $11.04 million -15.1%10.2%0.5 $12.27 5/28/20211,060,000 shares $14.43 million -27.9%12.1%0.6 $13.61 5/14/20211,470,000 shares $13.58 million +135.1%16.7%0.8 $9.24 4/30/2021625,400 shares $2.96 million +36.6%7.1%0.4 $4.73 4/15/2021457,900 shares $2.90 million +3.0%5.2%1.9 $6.33 3/31/2021444,400 shares $3.44 million +33.1%5.1%1.9 $7.74 3/15/2021333,800 shares $2.68 million -8.3%3.8%1.4 $8.03 2/26/2021363,800 shares $2.55 million +31.9%4.1%1.6 $7.02 2/12/2021275,800 shares $2.25 million +119.2%3.1%1.3 $8.14 1/29/2021125,800 shares $549.75 thousand +1.7%1.4%0.7 $4.37 1/15/2021123,700 shares $528.20 thousand +3.9%1.4%2.6 $4.27 12/31/2020119,100 shares $481.16 thousand -32.6%1.4%3.1 $4.04 12/15/2020176,600 shares $651.65 thousand +72.3%2.0%4.1 $3.69 11/30/2020102,500 shares $436.65 thousand +5.3%1.2%2.6 $4.26 11/15/202097,300 shares $388.23 thousand +1.0%1.1%2 $3.99 10/30/202096,300 shares $348.61 thousand -5.1%1.1%1.9 $3.62 10/15/2020101,500 shares $379.61 thousand +2.5%1.2%1.6 $3.74He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now NMRD Short Interest - Frequently Asked Questions What is Nemaura Medical's current short interest? Short interest is the volume of Nemaura Medical shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 400 shares of NMRD short. 0.00% of Nemaura Medical's shares are currently sold short. Learn More on Nemaura Medical's current short interest. What is a good short interest percentage for Nemaura Medical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Nemaura Medical's floating shares are currently sold short. How does Nemaura Medical's short interest compare to its competitors? 0.00% of Nemaura Medical's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Nemaura Medical: Acutus Medical, Inc. (0.00%), Sonendo, Inc. (0.03%), Minerva Surgical, Inc. (0.00%), Motus GI Holdings, Inc. (0.11%), Viveve Medical, Inc. (0.03%), GE HealthCare Technologies Inc. (1.98%), Koninklijke Philips N.V. (0.26%), Zimmer Biomet Holdings, Inc. (3.00%), Smith & Nephew SNATS, Inc. (0.60%), Solventum Corporation (2.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Nemaura Medical stock? Short selling NMRD is an investing strategy that aims to generate trading profit from Nemaura Medical as its price is falling. NMRD shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nemaura Medical? A short squeeze for Nemaura Medical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NMRD, which in turn drives the price of the stock up even further. How often is Nemaura Medical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMRD, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Acutus Medical Short Squeeze Sonendo Short Squeeze Minerva Surgical Short Squeeze Motus GI Short Squeeze Viveve Medical Short Squeeze HeartBeam Short Squeeze Innovative Eyewear Short Squeeze NorthView Acquisition Short Squeeze GE HealthCare Technologies Short Squeeze Koninklijke Philips Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NMRD) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access